Comprehensive liquid biopsy analysis as a tool for the early detection of minimal residual disease in breast cancer

Liquid biopsy (LB) provides a unique minimally invasive tool to follow-up cancer patients over time, to detect minimal residual disease (MRD), to study metastasis-biology and mechanisms of therapy-resistance. Molecular characterization of CTCs offers additionally the potential to understand resistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Stergiopoulou, Dimitra, Markou, Athina, Strati, Areti, Zavridou, Martha, Tzanikou, Eleni, Mastoraki, Sophia, Kallergi, Galatea, Georgoulias, Vassilis, Lianidou, Evi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870904/
https://www.ncbi.nlm.nih.gov/pubmed/36690653
http://dx.doi.org/10.1038/s41598-022-25400-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870904/
https://www.ncbi.nlm.nih.gov/pubmed/36690653
http://dx.doi.org/10.1038/s41598-022-25400-1

Ejemplares similares